The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention, Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.
Drug Safety offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles published may be accompanied by plain language summaries to assist patients, caregivers and others in their understanding. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
Drug Safety is the official journal of the International Society of Pharmacovigilance.
Letter to the Editor
Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis”
Katsuhiro Toda (December 2018)
Correction to: Abstracts of the 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland, 11–14 November, 2018
- Journal Title
- Drug Safety
- Volume 1 / 1986 - Volume 41 / 2018
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
|Medical toxicology and adverse drug experience||0113-5244|
To view the rest of this content please follow the download PDF link above.